are diagnosed as Covid-19 patients by positive PCR test or by CT Scan
Exclusion criteria:pregnant and (...) with Covid-19 that will be Recipient of standard national protocol drugs + Vitamin C 500mg
Control Group: Patients with Covid-19 that will be Recipient of standard national protocol drugs + placebo of
The effect of naproxen on the healing process of COVID-19 patients
This double (...) :
Inclusion criteria: COVID-19 patients that have positive PCR test of nasopharyngeal sample or have positive (...) with Covid19 (improvement of fever, chills, cough and night sweats)
clinical trial. The study population includes all patients with COVID-19 referring to Abadan hospitals. All (...) severe symptoms of COVID-19 who were admitted to the infectious ward of Ayatollah Taleghani Hospital in (...)COVID-19 with severe symptoms and positive RT-PCR assay of nasopharyngeal samples
COVID-19 patients that have positive PCR test
COVID-19 patients that have positive by CT Scan for COVID-19.
Exclusion criteria: Pregnant or breast feeding women, Patients under 18 years of age (...) laboratory findings in patients with coronary hospitalization in Abadan hospitals.
individuals from COVID-19 who were admitted to Ayatollah Taleghani Hospital in Abadan; Women between the ages (...) myokin profile of patients improved from COVID-19
Clinical trial has three groups of selected (...) female patients improved from Covid-19, 33 people were purposefully and voluntarily selected and randomly
inflammatory biomarkers in patients with COVID-19
Clinical trial with control group, with parallel (...) performed on 88 patients with Covid-19 referring to the clinic of Razi Hospital in Ahvaz. Patients are (...) .
Participants/Inclusion and exclusion criteria:
Patients aged 18 to 65 years Laboratory confirmation of Covid-19
Ayatollah Taleghani Hospital in Abadan. The study was performed on 100 patients with COVID-19 who were (...) Study aim:
Comparison of the administration of vitamin D3 and N acetylcysteine tablets in COVID-19(...) /Inclusion and exclusion criteria:
Inclusion criteria: COVID-19 patients that have positive PCR test of
Determination of the effect of sofosbuvir/daclatasvir in COVID-19 patients
A clinical trial with a, with parallel control group, double-blind, randomized, phase 3, and multicenter groups per 1000 patients.
Settings and conduct:
The study is a double-blind clinical trial. The sample
control group, two-way blind, randomly, simple random method on 40 patients with COVID19.
Settings and (...)Abadan University of Medical Sciences. Reflexology sessions for the intervention group will be held for 6